Peter Valent
Impact in
- Immunology and Allergy top 0.02%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 374
- Acute Myeloid Leukemia Research 234
- Chronic Myeloid Leukemia Treatments 112
- Hematopoietic Stem Cell Transplantation 25
- Immunology 460
- Mast cells and histamine 446
- Co-authors
- Wolfgang R. Sperr (251 shared papers)Rudolf Valenta (132 shared papers)Cem Akin (55 shared papers)Hans‐Peter Horny (91 shared papers)Klaus Lechner (102 shared papers)Karl Sotlar (87 shared papers)Christian Sillaber (92 shared papers)Peter Bettelheim (53 shared papers)
- Journals
- Blood (174 papers)Leukemia (46 papers)Journal of Allergy and Clinical Immunology (46 papers)International Archives of Allergy and Immunology (40 papers)Leukemia Research (38 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Peter Valent
1.1k papers receiving 57.5k citations
Peter Valent's Hit Papers
Peers
Comparison fields: 5 of 158
- Immunology and Allergy 8k
- Hematology 15.4k
- Immunology 19.9k
- Genetics 1.6k
- Oncology 3.6k
Countries citing papers authored by Peter Valent
This map shows the geographic impact of Peter Valent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Valent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Valent more than expected).
Fields of papers citing papers by Peter Valent
This network shows the impact of papers produced by Peter Valent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Valent. The network helps show where Peter Valent may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Valent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.1k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revised International Prognostic Scoring System for Myelodysplastic Syndromes Hit paper breakdown → | 2012 | 2475 |
| 2 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1587 |
| 3 | Diagnostic criteria and classification of mastocytosis: a consensus proposal Hit paper breakdown → | 2001 | 894 |
| 4 | New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients Hit paper breakdown → | 2007 | 633 |
| 5 | 2007 | 614 | |
| 6 | Molecular International Prognostic Scoring System for Myelodysplastic Syndromes Hit paper breakdown → | 2022 | 588 |
| 7 | Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets Hit paper breakdown → | 2007 | 579 |
| 8 | 1991 | 578 | |
| 9 | Cancer stem cell definitions and terminology: the devil is in the details Hit paper breakdown → | 2012 | 576 |
| 10 | New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge Hit paper breakdown → | 2012 | 556 |
| 11 | 1992 | 555 | |
| 12 | Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes Hit paper breakdown → | 2012 | 535 |
| 13 | 2011 | 512 | |
| 14 | Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes Hit paper breakdown → | 2020 | 510 |
| 15 | Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts Hit paper breakdown → | 2016 | 495 |
| 16 | Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement Hit paper breakdown → | 2021 | 451 |
| 17 | 2015 | 437 | |
| 18 | 2007 | 419 | |
| 19 | 2015 | 408 | |
| 20 | 1992 | 376 |
About Peter Valent
Peter Valent is a scholar working on Hematology, Immunology, Immunology and Allergy, Genetics and Oncology, having authored 1.1k papers that have together received 59.6k indexed citations. Recurring topics across this work include Mast cells and histamine (446 papers), Acute Myeloid Leukemia Research (234 papers), Chronic Myeloid Leukemia Treatments (112 papers), Allergic Rhinitis and Sensitization (100 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers), Hematopoietic Stem Cell Transplantation (25 papers), Eosinophilic Disorders and Syndromes (21 papers) and Cytokine Signaling Pathways and Interactions (16 papers). The work is most often cited by research in Immunology and Allergy (8k citations), Hematology (15.4k citations), Immunology (19.9k citations), Genetics (1.6k citations) and Oncology (3.6k citations). Peter Valent has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Wolfgang R. Sperr, Rudolf Valenta, Cem Akin, Hans‐Peter Horny, Klaus Lechner, Karl Sotlar, Christian Sillaber, Peter Bettelheim, Dean D. Metcalfe and Dietrich Kraft. Their work appears in journals such as Blood, Leukemia, Journal of Allergy and Clinical Immunology, International Archives of Allergy and Immunology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.